20 Healthcare Stocks Moving In Thursday's Pre-Market Session

Gainers

• HEXO, Inc. HEXO stock increased by 27.45% to $1.30 during Thursday's pre-market session. The most recent rating by Roth Capital, on Mar 31, is at Neutral, with a price target of $1.

• Onconova Therapeutics, Inc. ONTX shares increased by 25.78% to $0.60.

• Viveve Medical, Inc. VIVE shares increased by 18.78% to $0.86.

• Sorrento Therapeutics, Inc. SRNE shares rose 11.23% to $5.05. The most recent rating by Dawson James, on May 26, is at Buy, with a price target of $24.

• Aileron Therapeutics, Inc. ALRN shares increased by 10.40% to $1.38. The most recent rating by HC Wainwright & Co., on Jun 5, is at Buy, with a price target of $2.

• FSD Pharma, Inc. HUGE stock moved upwards by 10.21% to $5.29.

• Hepion Pharmaceuticals, Inc. HEPA stock rose 9.05% to $2.53.

• Strata Skin Sciences, Inc. SSKN shares increased by 8.80% to $1.36. According to the most recent rating by HC Wainwright & Co., on Mar 17, the current rating is at Neutral.

• AnaptysBio, Inc. ANAB stock rose 8.25% to $21.92. The most recent rating by Credit Suisse, on May 7, is at Neutral, with a price target of $16.

• Eyegate Pharmaceuticals, Inc. EYEG shares moved upwards by 8.06% to $5.90. The most recent rating by HC Wainwright & Co., on May 19, is at Buy, with a price target of $12.

Losers

• Mustang Bio, Inc. MBIO shares declined 24.13% to $3.49 during Thursday's pre-market session. The most recent rating by Oppenheimer, on May 12, is at Outperform, with a price target of $13.

• Immuron, Inc. IMRN shares fell 24.09% to $7.50.

• Trxade Group, Inc. MEDS stock fell 16.67% to $5.50.

• Intec Pharma, Inc. NTEC stock declined 13.86% to $0.35.

• Dynatronics, Inc. DYNT stock fell 13.66% to $0.85. The most recent rating by Aegis Capital, on May 19, is at Buy, with a price target of $1.

• Check-Cap, Inc. CHEK stock fell 12.49% to $0.55. The most recent rating by H.C. Wainwright, on Apr 24, is at Buy, with a price target of $2.

• Avinger, Inc. AVGR stock fell 11.54% to $0.46. The most recent rating by Aegis Capital, on May 15, is at Buy, with a price target of $1.

• Milestone Pharmaceuticals, Inc. MIST shares decreased by 11.11% to $4. According to the most recent rating by Jefferies, on Mar 25, the current rating is at Hold.

• NeuroMetrix, Inc. NURO shares decreased by 11.06% to $1.85.

• Xenetic Biosciences, Inc. XBIO shares declined 10.69% to $1.17.